Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00FPJ
|
|||
| Former ID |
DNC005330
|
|||
| Drug Name |
3,4,6-Trihydroxy-2-(4-hydroxy-phenyl)-inden-1-one
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H10O5
|
|||
| Canonical SMILES |
C1=CC(=CC=C1C2C(=O)C3=C(C2=O)C(=CC(=C3)O)O)O
|
|||
| InChI |
1S/C15H10O5/c16-8-3-1-7(2-4-8)12-14(19)10-5-9(17)6-11(18)13(10)15(12)20/h1-6,12,16-18H
|
|||
| InChIKey |
GXKXWCKNQMYETG-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Estrogen receptor beta (ESR2) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Estrogen signaling pathway | |||
| Prolactin signaling pathway | ||||
| Pathway Interaction Database | Plasma membrane estrogen receptor signaling | |||
| Validated nuclear estrogen receptor beta network | ||||
| Validated nuclear estrogen receptor alpha network | ||||
| Reactome | Nuclear Receptor transcription pathway | |||
| WikiPathways | SIDS Susceptibility Pathways | |||
| Ovarian Infertility Genes | ||||
| Integrated Pancreatic Cancer Pathway | ||||
| Nuclear Receptors | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones. Bioorg Med Chem Lett. 2005 Jun 15;15(12):3137-42. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.